针灸对韩国糖尿病患者心血管并发症的疗效:全国性回顾性队列研究
该研究基于韩国国民健康保险服务-全国样本队列(NHIS-NSC)数据,纳入2003至2006年间新诊断糖尿病且服用降糖药的40-79岁患者21232例,比较接受针灸(至少3次)与未接受针灸者的大血管并发症风险。经1:1倾向性评分匹配后每组各3350例,针灸组主要不良心血管事件(MACE)风险(HR 0.87;95%CI 0.81-0.94;P=0.0003)及全因死亡率(HR 0.77;95%CI 0.70-0.84;P<0.0001)均低于非针灸组。
要点
- 针灸组糖尿病患者MACE风险显著低于非针灸组(HR 0.87)。
- 针灸组全因死亡率较非针灸组降低23%(HR 0.77)。
- 因心血管病、缺血性心脏病及循环系统疾病死亡风险在针灸组更低。
核心结论
- 接受针灸治疗的糖尿病患者可能具有较低的主要不良心血管事件、全因死亡及心血管死亡风险。
研究设计与样本
- 全国性回顾性队列研究,使用韩国NHIS-NSC数据库,纳入2003-2006年新诊断且服降糖药的40-79岁糖尿病患者21232例,按是否接受至少3次针灸分组,经1:1倾向性评分匹配后每组3350例。
主要发现
- 匹配后针灸组MACE发生率低于非针灸组(HR 0.87;95%CI 0.81-0.94;P=0.0003)。
- 针灸组全因死亡率低于非针灸组(HR 0.77;95%CI 0.70-0.84;P<0.0001)。
- 二次分析中,针灸组卒中相关死亡率(HR 0.75;95%CI 0.56-1.00;P=0.0485)、缺血性心脏病死亡率(HR 0.53;95%CI 0.34-0.84;P=0.006)及循环系统疾病死亡率(HR 0.67;95%CI 0.55-0.82;P<0.0001)均低于非针灸组。
临床怎么用
- 对于服用降糖药的糖尿病患者,在常规治疗基础上可考虑结合针灸作为辅助手段,以潜在降低大血管并发症风险。
局限性
- 本研究为回顾性观察性研究,可能存在未测量的混杂因素,因果推断受限,尚需前瞻性队列或实验研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The main aim of this study is to investigate whether acupuncture could be an effective complementary treatment for reducing the risk of macrovascular complications in diabetic patients currently taking antidiabetic medications using a nationwide population-based database. METHODS: We conducted a retrospective cohort study to assess the efficacy of acupuncture on cardiovascular complications in diabetic patients using data from patients between 40 and 79 years of age, newly diagnosed with diabetes between 2003 and 2006, found in the National Health Insurance Service-National Sample Cohort (NHIS-NSC) in Korea. From the data, we identified 21,232 diabetic patients who were taking antidiabetic medication between 2003 and 2006. The selected patients were divided into two groups-those who received acupuncture at least three times and those who received no acupuncture (non-acupuncture) in the year following their diagnosis of diabetes. After 1:1 propensity score matching (PSM), each group had 3350 patients, and the observation ceased at the occurrence of a major adverse cardiovascular event (MACE), which was defined as either myocardial infarction, stroke, or death due to cardiovascular cause. RESULTS: After PSM, the acupuncture group had a lower incidence of MACE (hazard ratio [HR]: 0.87; 95% confidence interval [CI]: 0.81-0.94; P = 0.0003) and all-cause mortality (HR: 0.77; 95% CI: 0.70-0.84; P < 0.0001) than the non-acupuncture group; the HRs for stroke-related mortality (HR: 0.75; 95% CI: 0.56-1.00; P = 0.0485), ischemic heart disease mortality (HR: 0.53; 95% CI: 0.34-0.84; P = 0.006) and circulatory system disease mortality (HR: 0.67; 95% CI: 0.55-0.82; P < 0.0001) were lower in the acupuncture group than in the non-acupuncture group in the secondary analysis. CONCLUSION: Our results indicate that diabetic patients receiving acupuncture treatment might have a lower risk of MACE, all-cause mortality and cardiovascular mortality. This population-based retrospective study suggests beneficial effects of acupuncture in preventing macrovascular complications associated with diabetes. These findings call for further prospective cohort or experimental studies on acupuncture treatment for cardiovascular complications of diabetes. Please cite this article as: Jung H, Won T, Kim GY, Jang J, Yeo S, Lim S. Efficacy of acupuncture on cardiovascular complications in patients with diabetes mellitus in Korea: A nationwide retrospective cohort. J Integr Med. 2023; 21(2): 176-183.
引用
- Jung H, Won T, Kim GY, et al. Efficacy of acupuncture on cardiovascular complications in patients with diabetes mellitus in Korea: A nationwide retrospective cohort. J Integr Med. 2023. PMID: 36797171. doi:10.1016/j.joim.2023.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。